Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX)

CUSIP: 15117B202

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
67,629,115
Total 13F shares
3,466,005
Share change
+862,381
Total reported value
$9,286,115
Put/Call ratio
57%
Price per share
$2.68
Number of holders
39
Value change
+$2,108,302
Number of buys
19
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 15117B202?
CUSIP 15117B202 identifies CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX) as of Q2 2019

As of 30 Jun 2019, Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,466,005 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Cresset Asset Management, LLC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, TSP Capital Management Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, and A.R.T. Advisors, LLC. This page lists 39 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.